Apixaban News and Research

RSS
Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

Clinical presentation of monkeypox infection in two Israeli males

Clinical presentation of monkeypox infection in two Israeli males

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

Many treatments for intracerebral hemorrhage are not as effective as previously thought, guideline suggests

New type of anti-clotting drug reduces bleeding incidents among patients with atrial fibrillation

New type of anti-clotting drug reduces bleeding incidents among patients with atrial fibrillation

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

Meta-analysis finds intensified anticoagulation had no effect on short term mortality among hospitalized COVID-19 patients

World-renowned expert to lead pediatric cardiology division at Washington University School of Medicine

World-renowned expert to lead pediatric cardiology division at Washington University School of Medicine

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Study elucidates the use of anticoagulants to treat bleeding in patients with gastrointestinal cancers

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Study shows adverse outcomes associated with use of more blood thinners

Study shows adverse outcomes associated with use of more blood thinners

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

International trial of blood thinners for COVID-19 treatment begins

International trial of blood thinners for COVID-19 treatment begins

D-dimer - A sensitive novel biomarker of COVID-19 mortality

D-dimer - A sensitive novel biomarker of COVID-19 mortality

Blood thinners help reduce the risk of COVID-19 deaths, study finds

Blood thinners help reduce the risk of COVID-19 deaths, study finds

Anticoagulation therapy associated with improved survival among COVID-19 patients

Anticoagulation therapy associated with improved survival among COVID-19 patients

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Secondary analysis reinforces safety of blood thinner

Secondary analysis reinforces safety of blood thinner

First reported occurrence and treatment of venous thrombosis during spaceflight

First reported occurrence and treatment of venous thrombosis during spaceflight

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study